title: Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece.
abstract: BACKGROUND
  Inheritance of a mutation in either BRCA1 or BRCA2 accounts for approximately 5% of all breast cancer cases, but varies by country. Investigations into the contribution of BRCA mutations to breast cancer incidence in Greece have been, for the most part, limited by small sample sizes and by the use of cases selected for their family history of cancer. The aim of the current study was to estimate BRCA mutation frequencies in breast cancer patients unselected for family history.
  
  
  METHODS
  To do so, we enrolled 127 unselected women with breast cancer from the Alexandra Hospital in Athens, Greece, a large public hospital in the city. Mutations in BRCA1 and BRCA2 were detected using a combination of techniques and were confirmed by direct sequencing. Two large genomic deletions were sought using mutation-specific assays. A detailed family history of cancer was obtained from each patient.
  
  
  RESULTS
  We were able to successfully complete testing on samples from 127 women. Among these, six mutations were identified (four in BRCA1 and two in BRCA2) representing 4.7% of the total or 9.5% of cases diagnosed before age forty. None of the mutation carriers had a family history of breast or ovarian cancer. Three of the four BRCA1 mutations were in exon 20: two were a G5331A mutation and the third was a 3.2 kb deletion. The fourth BRCA1 mutation was the 3819delGTAAA in exon 11. The two BRCA2 mutations were in exon 11 (3782del10 and 4512insT).
  
  
  CONCLUSIONS
  The G5331A mutation in BRCA1 appears to be a founder mutation in the Greek population.
authors.affiliation: Women's College Research Institute, Toronto, ON, Canada. joanne.kotsopoulos@wchospital.ca.
authors.forename: Chrissovaladis
authors.initials: C
authors.lastname: Koumpis
authors.forename: Constantine
authors.initials: C
authors.lastname: Dimitrakakis
authors.forename: Aris
authors.initials: A
authors.lastname: Antsaklis
authors.forename: Robert
authors.initials: R
authors.lastname: Royer
authors.forename: Shiyu
authors.initials: S
authors.lastname: Zhang
authors.forename: Steven A
authors.initials: SA
authors.lastname: Narod
authors.forename: Joanne
authors.initials: J
authors.lastname: Kotsopoulos
references.citation: Nat Rev Cancer. 2007 Dec;7(12):937-48
references.pmid: 18034184
references.citation: BMC Cancer. 2004 Sep 07;4:61
references.pmid: 15353005
references.citation: Breast Cancer Res Treat. 2008 Jul;110(2):377-85
references.pmid: 17902052
references.citation: Nat Rev Genet. 2003 Aug;4(8):598-612
references.pmid: 12897772
references.citation: J Clin Oncol. 2002 Jun 1;20(11):2701-12
references.pmid: 12039933
references.citation: Am J Hum Genet. 2000 Jun;66(6):1963-8
references.pmid: 10788334
references.citation: Br J Cancer. 2009 Jul 7;101(1):32-7
references.pmid: 19491894
references.citation: Ann Oncol. 2007 Jun;18 Suppl 6:vi93-8
references.pmid: 17591843
references.citation: Am J Hum Genet. 1995 Oct;57(4):957-8
references.pmid: 7573057
references.citation: Eur J Hum Genet. 2011 Mar;19(3):300-6
references.pmid: 21119707
references.citation: Am J Hum Genet. 1998 Nov;63(5):1341-51
references.pmid: 9792861
references.citation: Clin Genet. 2000 Mar;57(3):213-20
references.pmid: 10782928
references.citation: Hum Mutat. 2002 Jan;19(1):81-2
references.pmid: 11754111
references.citation: Am J Hum Genet. 2003 May;72(5):1117-30
references.pmid: 12677558
references.citation: Clin Genet. 2005 Apr;67(4):322-9
references.pmid: 15733268
references.citation: Fam Cancer. 2005;4(2):97-103
references.pmid: 15951959
references.citation: Lancet. 1994 Mar 19;343(8899):692-5
references.pmid: 7907678
references.citation: Breast Cancer Res. 2000;2(2):77-81
references.pmid: 11250694
references.citation: J Clin Oncol. 2007 Apr 10;25(11):1329-33
references.pmid: 17416853
references.citation: J Med Genet. 2002 Jul;39(7):457-62
references.pmid: 12114473
references.citation: Hum Mutat. 2000 Sep;16(3):272-3
references.pmid: 10980541
references.citation: Am J Hum Genet. 1995 Jul;57(1):189
references.pmid: 7611288
references.citation: Lancet. 2005 May 21-27;365(9473):1747-9
references.pmid: 15910935
references.citation: J Natl Cancer Inst. 1999 Aug 4;91(15):1310-6
references.pmid: 10433620
references.citation: Cancer Lett. 2002 Nov 8;185(1):61-70
references.pmid: 12142080
references.citation: J Natl Cancer Inst. 2002 Sep 18;94(18):1358-65
references.pmid: 12237281
references.citation: Cancer Control. 2002 Nov-Dec;9(6):457-65
references.pmid: 12514563
references.citation: Nat Rev Cancer. 2004 Sep;4(9):665-76
references.pmid: 15343273
references.citation: Breast Cancer Res Treat. 2008 Feb;107(3):431-41
references.pmid: 17453335